Arrowpoint Asset Management »

Nurix Therapeutics shares owned by Arrowpoint Asset Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Arrowpoint Asset Management from 13F filings

Historical chart of Arrowpoint Asset Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Arrowpoint Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 315k 10.32
2023-09-30 $2.5M 315k 7.86

More positions owned by Arrowpoint Asset Management

Alight Com Cl A (ALIT)
Rb Global (RBA)
J Global (ZD)
Trimble Navigation (TRMB)
Cargurus Com Cl A (CARG)
Euronet Worldwide (EEFT)
Matson (MATX)
Sensata Technologies Hldg Pl SHS (ST)
Quidel Corp (QDEL)
Steris Shs Usd (STE)
Acv Auctions Com Cl A (ACVA)
Merit Medical Systems (MMSI)
Churchill Downs (CHDN)
Okta Cl A (OKTA)
Kirby Corporation (KEX)

View all positions for Arrowpoint Asset Management

Top funds holding Nurix Therapeutics

Baker Bros. Advisors
Redmile Group
ARK Investment Management
Vanguard Group
T. Rowe Price Associates
Daniel D. Thurber
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Millennium Management
Bessemer
Arrowpoint Asset Management
Taddei, Ludwig & Associates
Goldman Sachs Group

View all funds holding Nurix Therapeutics